Scarica l'app Stockscreener
303.73
0.05%
-0.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$303.88
Aprire:
$303.88
Volume 24 ore:
130.01K
Relative Volume:
0.65
Capitalizzazione di mercato:
$8.19B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-11.11
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
-0.37%
1M Prestazione:
-6.50%
6M Prestazione:
+24.49%
1 anno Prestazione:
-8.20%
Intervallo 1D:
$301.07
$305.62
Intervallo di 1 settimana:
$298.78
$305.62
Portata 52W:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
303.73 | 8.20B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
124.57 | 217.08B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
95.76 | 142.40B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.50 | 135.46B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.15 | 123.74B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.94 | 50.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Boston Trust Walden Corp Invests $26.76 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Marathon Asset Management Ltd Sells 7,893 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Protein A Resin Market is expected to reach US$ 4.1 billion by 2032 - openPR.com
Newborn Screening Market Assessment 2032: Segment Analysis, - openPR.com
Japan's Life Sciences Research and Clinical Applications Fuel - openPR.com
BIO (Bio-Rad Laboratories) Sale Of Property, Plant, Equipme - GuruFocus
Harbor Capital Advisors Inc. Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com
United states IVD Quality Control Market expected to grow at - openPR.com
United states Molecular Quality Controls Market expected - openPR.com
Bio-Rad Laboratories Earnings Notes - Trefis
Robust Growth in Molecular Quality Control Market (2025-2032): - openPR.com
Exchange Traded Concepts LLC Buys 7,648 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Life Science Instruments & Consumables Market to Reach USD - openPR.com
Enzyme-Linked Immunosorbent Assay Market is expected to reach - openPR.com
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO - FinancialContent
Cell Viability Assays Market Soars as Drug Discovery Demand - openPR.com
Why Bio Rad Laboratories Inc. stock attracts global investorsTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
Published on: 2025-12-20 23:30:31 - Улправда
Can Bio Rad Laboratories Inc. (BUW) stock sustain margin levelsJuly 2025 PostEarnings & Risk Managed Trade Strategies - bolumsonucanavari.com
How Bio Rad Laboratories Inc. stock performs in interest rate cycles2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
Published on: 2025-12-20 08:31:22 - Улправда
Will Bio Rad Laboratories Inc. stock recover faster than marketMarket Sentiment Review & Safe Entry Point Identification - Улправда
Is Bio Rad Laboratories Inc. stock resilient to inflationJuly 2025 Institutional & High Accuracy Swing Entry Alerts - ulpravda.ru
Why Bio Rad Laboratories Inc. stock is trending among retail tradersJuly 2025 Snapshot & Capital Efficient Trade Techniques - Bölüm Sonu Canavarı
Why Bio Rad Laboratories Inc. stock is rated strong buy2025 Biggest Moves & Weekly Return Optimization Plans - ulpravda.ru
Why Bio Rad Laboratories Inc. (BUW) stock is a must watch tickerMarket Sentiment Report & Real-Time Buy Zone Alerts - DonanımHaber
Is Bio Rad Laboratories Inc. stock a smart buy before Fed meetingJuly 2025 Retail & Entry Point Confirmation Alerts - DonanımHaber
Published on: 2025-12-19 13:52:52 - DonanımHaber
Is Bio Rad Laboratories Inc. stock in correction or buying zone2025 Performance Recap & Low Drawdown Momentum Trade Ideas - DonanımHaber
Liquidity Mapping Around (BIO) Price Events - Stock Traders Daily
Loss Report: Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed action - Улправда
Guidance Update: Will Bio Rad Laboratories Inc. stock gain from government policies2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Улправда
Bio-Rad Laboratories (FRA:BUWA) EV-to-FCF : 22.87 (As of Dec. 18, 2025) - GuruFocus
Assessment of InteliQ Multiqual Tube-Based QC Materials - Labroots
In Vitro Toxicity Testing Market Set for Dynamic Growth with Key - openPR.com
Published on: 2025-12-18 13:31:33 - Улправда
Is Bio Rad Laboratories Inc. stock a safe investment in uncertain marketsJuly 2025 Rallies & Risk Controlled Daily Plans - Улправда
Bio-Rad Laboratories Mourns Loss of Co-Founder Alice Schwartz - MSN
Published on: 2025-12-18 04:48:11 - moha.gov.vn
Multi Omics Platform Market Outlook 2025-2032: Key Trends, Size - openPR.com
Nucleic Acid Extraction Equipment Market Analysis Report 2025-2034 - Insightace Analytic
Establishing Best Practices in Quality Control Management - Labroots
DNA/RNA Extraction Kit Market to Reach US$ 5.12 Billion by 2033 - openPR.com
Fragment Analysis Market 2025-2032: Growth Overview, Facts & - openPR.com
Biodesix and Bio-Rad Laboratories Team Up on Droplet Digital PCR Assays - Medical Product Outsourcing
Is Bio-Rad (BIO) Quietly Repositioning Its Moat Around Automation‑Led Blood Diagnostics? - Sahm
IVD Diagnostic Molecule Raw Enzymes Market Forecast to Grow at 7.13% CAGR by 2034 - GlobeNewswire Inc.
MASTERINVEST Kapitalanlage GmbH Acquires New Shares in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United States DNA Sequencing Market 2031 | Growth Drivers, Key - openPR.com
Bio-Rad launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for antibody conjugation to StarBright Dyes - MSN
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.44%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):